Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 06:58 am Purchase | 2024-09-30 | 13G | Immunic, Inc. IMUX | RTW Investments, LP | 5,594,479 6.100% | 1,259,224 (+29.05%) | Filing History |
| 2024-11-12 3:51 pm Unchanged | 2024-09-30 | 13G | Immunic, Inc. IMUX | The Vanguard Group | 4,700,016 5.210% | 0 (Unchanged) | Filing History |
| 2024-11-12 09:31 am Purchase | 2024-09-30 | 13G | Immunic, Inc. IMUX | Adage Capital Management, L.P. | 5,594,406 6.210% | 5,594,406 (New Position) | Filing History |
| 2024-11-04 11:49 am Purchase | 2024-09-30 | 13G | Immunic, Inc. IMUX | The Vanguard Group | 4,700,016 5.210% | 4,700,016 (New Position) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | Immunic, Inc. IMUX | Commodore Capital LP | 0 0.000% | -2,873,563 (Position Closed) | Filing History |
| 2024-02-14 08:47 am Sale | 2023-12-31 | 13G | Immunic, Inc. IMUX | Deep Track Capital, LP | 0 0.000% | -4,022,989 (Position Closed) | Filing History |
| 2024-02-14 07:55 am Purchase | 2023-12-31 | 13G | Immunic, Inc. IMUX | RTW Investments, LP | 4,335,255 9.600% | 473,965 (+12.27%) | Filing History |
| 2024-01-18 4:18 pm Purchase | 2024-01-08 | 13G | Immunic, Inc. IMUX | BIOTECHNOLOGY VALUE FUND L P | 8,902,972 9.900% | 8,902,972 (New Position) | Filing History |
| 2024-01-18 11:49 am Purchase | 2024-01-08 | 13G | Immunic, Inc. IMUX | JANUS HENDERSON GROUP PLC JHG | 6,693,007 7.400% | 6,693,007 (New Position) | Filing History |
| 2024-01-16 4:12 pm Purchase | 2024-01-04 | 13G | Immunic, Inc. IMUX | Avidity Partners Management LP | 8,899,418 9.900% | 8,899,418 (New Position) | Filing History |
| 2024-01-10 09:00 am Purchase | 2024-01-08 | 13G | Immunic, Inc. IMUX | Soleus Private Equity Fund III, L.P. | 7,293,007 8.100% | 7,293,007 (New Position) | Filing History |
| 2023-02-24 07:00 am Unchanged | 2023-02-23 | 13D | Immunic, Inc. IMUX | LSP V Cooperatieve U.A. | 2,162,782 4.900% | 0 (Unchanged) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Immunic, Inc. IMUX | Commodore Capital LP | 2,873,563 6.300% | -893,013 (-23.71%) | Filing History |
| 2023-02-14 10:06 am Purchase | 2022-12-31 | 13G | Immunic, Inc. IMUX | RTW Investments, LP | 3,861,290 8.700% | 2,145,820 (+125.09%) | Filing History |
| 2023-02-14 08:36 am Unchanged | 2022-12-31 | 13G | Immunic, Inc. IMUX | Deep Track Capital, LP | 4,022,989 8.320% | 0 (Unchanged) | Filing History |
| 2023-02-13 4:41 pm Purchase | 2022-12-20 | 13D | Immunic, Inc. IMUX | Global Life Bioventure V Sarl | 1,849,786 4.200% | 43,873 (+2.43%) | Filing History |
| 2022-11-28 11:41 am Purchase | 2022-11-17 | 13G | Immunic, Inc. IMUX | Oetker-von Franquet Suzanne Madeleine | 1,974,571 5.000% | 1,974,571 (New Position) | Filing History |
| 2022-11-25 08:41 am Purchase | 2022-11-17 | 13G | Immunic, Inc. IMUX | ROI VERWALTUNGS GMBH | 1,974,571 5.000% | 1,974,571 (New Position) | Filing History |
| 2022-11-25 08:35 am Purchase | 2022-11-17 | 13G | Immunic, Inc. IMUX | Oetker Roland | 1,974,571 5.000% | 909,993 (+85.48%) | Filing History |
| 2022-10-24 4:37 pm Purchase | 2022-10-12 | 13G | Immunic, Inc. IMUX | Point72 Asset Management, L.P. | 1,917,546 4.900% | 1,917,546 (New Position) | Filing History |